Literature DB >> 32777827

Endoscopic sleeve gastroplasty: suturing the gastric fundus does not confer benefit.

Jad Farha1, Christopher McGowan2, Abdellah Hedjoudje1, Mohamad I Itani1, Shahem Abbarh1, Cem Simsek1, Yervant Ichkhanian1, Trish Vulpis3, Theodore W James4, Lea Fayad1, Mouen A Khashab1, Andreas Oberbach1, Dilhana Badurdeen1, Vivek Kumbhari1.   

Abstract

BACKGROUND : There is heterogeneity regarding the technical aspects of endoscopic sleeve gastroplasty (ESG), such as applying fundal sutures. Our aim was to determine whether ESG with fundal suturing (ESG-FS) affects weight loss and the serious adverse event (SAE) rate when compared with ESG with no fundal suturing (ESG-NFS).
METHODS:  We conducted a two-center retrospective analysis of 247 patients who underwent ESG with or without fundal suturing. The primary outcome was percentage excess weight loss (%EWL) at 3, 6, and 12 months post-ESG. The secondary outcomes included the SAE rate and procedure duration.
RESULTS:  At 3, 6, and 12-months, ESG-NFS had a significantly greater mean %EWL compared with ESG-FS (38.4 % [standard deviation (SD) 15.3 %] vs. 31.2 % [SD 13.9 %], P = 0.001; 54.7 % [SD 19.2 %] vs. 37.7 % [SD 17.3 %], P < 0.001; 65.3 % [SD 21.1 %] vs. 40.6 % [SD 23.5 %], P < 0.001, respectively). There was no statistically significant difference in the SAE rates for ESG-NFS (n = 2; 2.0 %) and ESG-FS (n = 4; 2.6 %; P > 0.99). The mean procedure time was significantly shorter in the ESG-NFS group at 59.1 minutes (SD 32.7) vs. 93.0 minutes (35.5; P < 0.001), and a lower mean number of sutures were used, with 5.7 (SD 1.1) vs. 8.4 (SD 1.6; P < 0.001). CONCLUSION : ESG-NFS demonstrated greater efficacy and shorter procedure duration. Therefore, fundal suturing should not be performed. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32777827     DOI: 10.1055/a-1236-9347

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   9.776


  2 in total

1.  Impact of Proceduralist Specialty on Outcomes Following Endoscopic Sleeve Gastroplasty.

Authors:  Anuragh R Gudur; Calvin Geng; Peter Hallowell; Bruce Schirmer; Vanessa M Shami; Andrew Y Wang; Alexander Podboy
Journal:  Obes Surg       Date:  2022-09-28       Impact factor: 3.479

2.  Safety and early efficacy of endoscopic sleeve gastroplasty (ESG) for obesity in a multi-ethnic Asian population in Singapore.

Authors:  Ravishankar Asokkumar; Chin Hong Lim; Ai Shan Tan; Phong Ching Lee; Alvin Eng; Jeremy Tan; Gontrand Lopez-Nava; Sonali Ganguly; Jason Chang; Christopher Khor
Journal:  JGH Open       Date:  2021-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.